Autopsy reveals drugs did not contribute to Cornell's death

Image
ANI New York [USA]
Last Updated : Jun 05 2017 | 9:13 PM IST

According to the autopsy reports of late Chris Cornell, the singer had several prescription drugs in his system but those did not contribute to the singer's death.

According to CNN, toxicology tests showed the presence of barbiturates, caffeine and lorazepam, also known as Ativan, for relief of anxiety.

Dr Theodore Brown, assistant Wayne County medical examiner, shared, "These drugs did not contribute to the cause of death."

Wife Vicky Cornell said that she talked to Chris immediately after the Detroit show and he had indicated that he might have taken extra Ativan.

Vicky said in a statement, "Many of us who know Chris well noticed that he wasn't himself during his final hours and that something was very off. We have learned from this report that several substances were found in his system. After so many years of sobriety, this moment of terrible judgment seems to have completely impaired and altered his state of mind."

The official autopsy results rule the cause of death as suicide by hanging.

Cornell's family has disputed that his death was intentional.

The statement continued, "We very much appreciate all of the love we have received during this extremely difficult time and are dedicated to helping others in preventing this type of tragedy."

The frontman for Soundgarden and Audioslave, 52, was found dead with a band around his neck inside his hotel room at the MGM Grand Hotel in Detroit following a concert.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 05 2017 | 9:13 PM IST

Next Story